MOTS-c explainedCompound research

MOTS-c Benefits People Search For

Learn why people search for MOTS-c benefits related to energy, metabolism, body composition, recovery, and healthy aging, plus what studies have found.

Fnx Education DeskReviewed by Fnx PerformanceAugust 25, 20265 min read

False-color microscopy-style view of a mitochondrion and its folded cristae inside skeletal muscle tissue. — A mitochondrion within skeletal muscle tissue, with its folded inner membrane visible in detail.

MOTS-c is a short peptide linked to mitochondria, the structures inside cells that help turn nutrients into usable energy. That origin has made it a frequent subject in conversations about exercise, metabolism, body composition, recovery, and aging.

Two research lines often get blended together: measurements of MOTS-c that the body makes on its own, and experiments that supply MOTS-c to cells or animals. The human work discussed here mainly covers the first line. Most proposed benefits come from the second.

Quick take

MOTS-c is a 16-amino-acid peptide encoded within mitochondrial DNA.

A 2021 study tracked the body's own MOTS-c levels around exercise in 10 healthy young men.

Most discussions of performance, metabolism, body composition, recovery, and aging come from cell and mouse studies.

MOTS-c in plain language

Researchers first described MOTS-c in 2015. Its name comes from mitochondrial open reading frame of the 12S rRNA type-c, and its sequence contains 16 amino acids. It belongs to a group called mitochondrial-derived peptides, which researchers study as signals produced from mitochondrial genetic material.

Mitochondria supply energy to cells, respond to stress, and communicate with other parts of the cell. Laboratory research links MOTS-c with the folate cycle, purine synthesis, AMPK signaling, glucose use, and changes in gene activity. These mechanisms explain why metabolism and exercise appear so often in discussions about the peptide.

In cell experiments, researchers traced part of the MOTS-c response through AMPK, a pathway that helps cells sense and manage energy stress. That pathway became a working explanation for the changes in glucose use and skeletal-muscle metabolism later observed in mouse studies.

What human research has measured

A 2021 Nature Communications paper followed 10 sedentary, healthy young men during a stationary cycling session. Researchers collected blood and skeletal-muscle samples before and after exercise, with additional blood sampling during the session and after four hours of rest.

MOTS-c levels rose in skeletal muscle after exercise and remained elevated after the rest period, although they were moving back toward baseline. Circulating levels rose during and after exercise, then returned to baseline after four hours. In this small group, the body's own MOTS-c responded to physical exertion.

The participants were not given MOTS-c; the study followed the peptide produced naturally inside the body. This gave researchers a time course for MOTS-c as an exercise-responsive signal, from the rise during and after the ride to the return toward baseline during recovery.

Energy, exercise, and metabolism

The exercise claims associated with MOTS-c mostly trace back to mouse experiments in the same 2021 paper. Researchers reported better physical performance in young, middle-aged, and old mice under controlled conditions. They also studied skeletal-muscle metabolism, gene activity, and the way muscle cells adapted to metabolic stress.

Metabolic interest reaches back to the 2015 Cell Metabolism paper. In cell experiments, researchers examined glucose use and pathways involving AMPK. In mice, they reported findings involving insulin sensitivity, high-fat-diet-related obesity, and age-related metabolic changes.

A 2023 review brings together findings across tissues, health conditions, and experimental models. Human observational studies have also recorded different MOTS-c levels across metabolic conditions, adding another line of research into how the peptide tracks with metabolic state.

Across the mouse studies, researchers reported longer running time, greater endurance and maximum speed, better glucose handling, higher heat production, and shifts in fuel use. In the high-fat-diet experiments, caloric intake and total activity were comparable between groups, helping researchers separate the metabolic changes from simply eating less or moving more.

Body composition, recovery, and healthy aging

Body composition

Interest in body composition comes from mouse studies involving high-fat diets, weight gain, fat accumulation, glucose handling, and energy expenditure. The 2021 paper also reported changes in fat gain and lean mass in young mice under specific experimental conditions.

In high-fat-diet studies, treated mice gained less weight and accumulated less fat while consuming the same number of calories. Researchers also reported less liver-fat accumulation, higher heat production, and greater glucose use. In the late-life study, treated older mice had lower fat mass and a modest reduction in age-related lean-mass loss.

Recovery and resilience

Recovery can mean soreness, sleep, readiness to train, healing after injury, or the time needed to return to baseline. Resilience can describe a cellular stress response or a person's ability to tolerate physical work. Each outcome needs its own measurement.

In mouse muscle and cultured mouse muscle cells, MOTS-c changed genes involved in metabolism and protein stability and helped cells adapt to metabolic stress. Researchers also tracked skeletal-muscle metabolism and muscle-cell development, which is why recovery and resilience appear so often in discussions around MOTS-c.

Healthy aging and longevity

The 2021 paper reported physical-capacity and healthspan-related findings in mice, including older mice. The 2023 review covers wider research on mitochondrial stress, age-related metabolism, and several animal disease models.

In the late-life mouse study, treatment began at about 23.5 months of age. At more than 30 months, treated mice showed stronger grip, longer stride length, and better performance on a 60-second walking test. The lifespan curve also trended upward, although the overall difference did not reach statistical significance.

False-color microscopy-style view of multiple mitochondria distributed between skeletal muscle fibers. — Mitochondria distributed through skeletal muscle tissue.

Where MOTS-c research is heading

MOTS-c belongs to a wider group of mitochondrial-derived signaling peptides that includes humanin and six small humanin-like peptides, or SHLPs. Researchers have examined this group in metabolism, cellular stress, exercise, and aging. That gives MOTS-c a broader context than any single benefit claim.

A registered human trial is now testing supplied MOTS-c in a defined metabolic setting. ClinicalTrials.gov lists MOTS-MET as a recruiting Phase 2a study that plans to enroll an estimated 120 adults with prediabetes and overweight or obesity. It compares investigational MOTS-c with placebo over 12 weeks while both groups receive the same lifestyle counseling.

The trial centers on insulin sensitivity and also tracks HbA1c, fasting glucose, two-hour glucose after an oral glucose tolerance test, adverse events, and anti-drug antibodies. Its primary completion is estimated for February 2027, and no results have been posted yet.

Beyond that metabolic trial, possible research protocols could ask narrower questions about exercise, recovery, or aging. An exercise study, for example, could pair blood and muscle MOTS-c measurements with defined performance and recovery tests. Comparison studies could examine MOTS-c, humanin, and SHLPs separately before testing combinations, giving researchers a way to see where their signals overlap and where they differ.

The next chapter for MOTS-c

Current research places MOTS-c at the intersection of metabolism, exercise response, and mitochondrial signaling. MOTS-MET is designed to add placebo-controlled data in a defined metabolic population. Separate future protocols can explore performance, recovery, aging, and comparisons with other mitochondrial-derived peptides.

Sources

Zelle

VISA

PayPal

Crypto

For Research Use Only. Not for human or animal consumption. These statements have not been evaluated by the FDA. Products are not intended to diagnose, treat, cure, or prevent any disease.

Support email: support@fnxperformancelabs.com

Support phone: 808-620-1169

Business address:

2343 W 227th St

Torrance, CA 90501

United States